Argentine program of home infusions with enzyme replacement therapy for lysosomal diseases: Results in safety, quality of life and adherence
- 11 March 2025
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 145 (1) , 109076
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective studyOrphanet Journal of Rare Diseases, 2023
- Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional studyBMC Family Practice, 2019
- The pathogenesis of lysosomal storage disorders: beyond the engorgement of lysosomes to abnormal development and neuroinflammationHuman Molecular Genetics, 2018
- Epidemiology and diagnosis of lysosomal storage disorders; challenges of screeningBest Practice & Research Clinical Endocrinology & Metabolism, 2015
- The cellular pathology of lysosomal diseasesThe Journal of Pathology, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Enzyme reconstitution/replacement therapy for lysosomal storage diseasesCurrent Opinion in Pediatrics, 2007
- New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapyHuman Genetics, 2006
- PedsQL™ 4.0: Reliability and Validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in Healthy and Patient PopulationsMedical Care, 2001